Research Article
Clinical Usefulness of Bioavailable Vitamin D and Impact of GC Genotyping on the Determination of Bioavailable Vitamin D in a Korean Population
Table 3
Comparison of genotype-independent and genotype-specific bioavailable 25(OH)D concentrations according to medical status.
| | Genotype-independent bioavailable 25(OH)D (ng/ml) | Genotype-specific bioavailable 25(OH)D (ng/ml) | Mean percent difference between genotype-independent and genotype-specific bioavailable 25(OH)D | value |
| Total subjects () | 2.4 (1.4-3.6) | 2.5 (1.3-3.8) | 2.3% | 0.299 | Healthy controls () | 3.0 (2.6-4.3) | 2.9 (2.5-4.2) | -0.9% | 0.073 | Patients with LC () | 2.4 (1.4-3.9) | 3.0 (1.5-4.8) | 8.4% | 0.077 | Pregnant women () | 1.2 (0.8-1.7) | 1.2 (0.8-1.8) | -0.5% | 0.058 |
|
|
Values are presented with median (interquartile range). LC: liver cirrhosis; 25(OH)D: 25-hydroxy vitamin D.
|